New Current Report Filed with the SEC Relating to Statement that Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review Should Not Be Relied Upon: 8-K – Valeant Pharmaceuticals International, Inc. (0000885590) (Filer)





A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) relating to a statement that certain of the company’s previously-issued financial statements or a related audit report or completed interim review should not be relied upon by investors or other interested parties. Details of the current report are:

8-K – Valeant Pharmaceuticals International, Inc. (0000885590) (Filer)
Filed: 2016-03-21 AccNo: 0001193125-16-511157 Size: 75 KB

Item 2.02: Results of Operations and Financial Condition

Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Item 9.01: Financial Statements and Exhibits
Filing Date: 2016-03-21T09:14:30-04:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: http://www.sec.gov/Archives/edgar/data/885590/000119312516511157/0001193125-16-511157-index.htm